Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Pancreatic Neoplasms 43Triple Negative Breast Neoplasms 19Breast Neoplasms 15Carcinoma, Non-Small-Cell Lung 14Neoplasm Metastasis 10Lung Neoplasms 10Squamous Cell Carcinoma of Head and Neck 7Parkinson Disease 4, Autosomal Dominant Lewy Body 7Neoplasms 6Adenocarcinoma 6Cholangiocarcinoma 5Stomach Neoplasms 4Gallbladder Neoplasms 4Biliary Tract Neoplasms 4Uterine Cervical Neoplasms 3Recurrence 3Pancreatic Adenocarcinoma 3Ovarian Neoplasms 3Head and Neck Neoplasms 3Fallopian Tube Neoplasms 3Esophageal Squamous Cell Carcinoma 3Esophageal Neoplasms 3Endometrial Neoplasms 3Colorectal Neoplasms 3Small Cell Lung Carcinoma 2Sarcoma 2Rectal Neoplasms 2Colonic Neoplasms 2Carcinoma, Pancreatic Ductal 2Carcinoma, Hepatocellular 2

Interventions

Temozolomide 12Vincristine 9Irinotecan 8Cyclophosphamide 8cabozantinib 6X-Rays 5Specimen Handling 5Magnetic Resonance Spectroscopy 5Etoposide 5regorafenib 4fludarabine 4Radiotherapy 4Phantoms, Imaging 4Ifosfamide 4Doxorubicin 4Radiation 3ulixertinib 2tipifarnib 2tazemetostat 2selpercatinib 2palbociclib 2olaparib 2liposomal doxorubicin 2ivosidenib 2irinotecan sucrosofate 2etoposide phosphate 2abemaciclib 2Zoledronic Acid 2Topotecan 2Surgical Procedures, Operative 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Sarcoma, Ewing × Albumin-Bound Paclitaxel × 1 year × Clear all
NCT02945800 2026-04-02

Nab-Paclitaxel and Gemcitabine for Recurrent/Refractory Sarcoma

H. Lee Moffitt Cancer Center and Research Institute

Phase 2 Completed
59 enrolled 11 charts
Sarcoma

Recurrence, Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡